scispace - formally typeset
C

Cristina Tassorelli

Researcher at University of Pavia

Publications -  406
Citations -  19055

Cristina Tassorelli is an academic researcher from University of Pavia. The author has contributed to research in topics: Migraine & Medicine. The author has an hindex of 50, co-authored 346 publications receiving 15732 citations. Previous affiliations of Cristina Tassorelli include University of Rochester Medical Center & UniFi.

Papers
More filters
Journal ArticleDOI

Nonparalytic botulinum molecules for the control of pain

TL;DR: Results suggest that BiTox should be considered for treatment of pain conditions in which A-nociceptors are thought to play a significant role, and imply that although local release of neuromodulators from C-fibers was inhibited byBiTox injection, C- nociceptive signaling function was not impaired.
Journal ArticleDOI

Factors associated with a negative outcome of medication-overuse headache: A 3-year follow-up (the ‘CARE’ protocol):

TL;DR: Disease outcome in MOH patients is influenced negatively by overuse severity and by specific psychological and socio-economic variables.
Journal ArticleDOI

FAAH inhibition as a preventive treatment for migraine: A pre-clinical study.

TL;DR: The findings suggest that global FAAH inhibition may offer a therapeutic approach to the prevention, but not the treatment, of migraine attacks.
Journal ArticleDOI

Botulinum toxin is effective in the management of neurogenic dysphagia. clinical-electrophysiological findings and tips on safety in different neurological disorders

TL;DR: Findings confirm the effectiveness of IncobotulinumtoxinA injection in the treatment of neurogenic dysphagia due to hyperactivity and relaxation failure of the UES and should be used as regards, the re-injection in non-responders to the first treatment.
Journal ArticleDOI

Effects of nimesulide on nitric oxide-induced hyperalgesia in humans--a neurophysiological study.

TL;DR: Data suggest a central effect for nimesulide, possibly related to a reduction of nociceptive activity at spinal level, as a preferential inhibitor of the inducible isoform of cyclo-oxygenase-2.